Acquisitions and Other Transactions (Jai Pharma Limited) (Narrative) (Details) $ in Millions		12 Months Ended
	Nov. 20, 2015 USD ($) shareholder	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Business Acquisition [Line Items]
Goodwill		$ 5,380.1	$ 4,049.3	$ 4,340.5
Maximum
Business Acquisition [Line Items]
Rate used to discount net cash inflows to present values		9.80%	9.80%
Minimum
Business Acquisition [Line Items]
Rate used to discount net cash inflows to present values		0.90%	0.90%
Jai Pharma Limited
Business Acquisition [Line Items]
Acquisition purchase price	$ 750.0
Purchase consideration, contingent consideration, maximum	18.0
Net assets acquired	$ 711.1
Minimum number of former shareholders providing services | shareholder	1
Number of shareholders | shareholder	2
Post-acquisition consulting services period	2 years
Working capital and other adjustments excluded	$ 7.0
Research and development in process, expect completion cost		$ 5.0
Goodwill	317.2
Amount of goodwill expected to be tax deductible		0.0
Acquisition related costs		$ 8.5
Jai Pharma Limited | Product rights and licenses
Business Acquisition [Line Items]
Identified intangible assets	$ 437.0
Acquired intangible assets, weighted average useful life, in years	9 years
Jai Pharma Limited | Maximum
Business Acquisition [Line Items]
Purchase consideration, contingent consideration, maximum	$ 50.0
Rate used to discount net cash inflows to present values	11.00%
Jai Pharma Limited | Minimum
Business Acquisition [Line Items]
Rate used to discount net cash inflows to present values	10.00%